- Home
- NMT vs NTRB Comparison
NMT vs NTRB Comparison
Compare NMT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMT
- NTRB
- Stock Information
- Founded
- NMT 1993
- NTRB 2016
- Country
- NMT United States
- NTRB United States
- Employees
- NMT N/A
- NTRB N/A
- Industry
- NMT Finance/Investors Services
- NTRB Industrial Specialties
- Sector
- NMT Finance
- NTRB Health Care
- Exchange
- NMT Nasdaq
- NTRB Nasdaq
- Market Cap
- NMT 107.8M
- NTRB 93.2M
- IPO Year
- NMT N/A
- NTRB N/A
- Fundamental
- Price
- NMT $11.47
- NTRB $5.98
- Analyst Decision
- NMT
- NTRB Buy
- Analyst Count
- NMT 0
- NTRB 1
- Target Price
- NMT N/A
- NTRB $13.00
- AVG Volume (30 Days)
- NMT 19.1K
- NTRB 48.3K
- Earning Date
- NMT 01-01-0001
- NTRB 12-03-2025
- Dividend Yield
- NMT 3.21%
- NTRB N/A
- EPS Growth
- NMT N/A
- NTRB N/A
- EPS
- NMT N/A
- NTRB N/A
- Revenue
- NMT N/A
- NTRB $2,578,059.00
- Revenue This Year
- NMT N/A
- NTRB $560.75
- Revenue Next Year
- NMT N/A
- NTRB $588.39
- P/E Ratio
- NMT N/A
- NTRB N/A
- Revenue Growth
- NMT N/A
- NTRB 42.92
- 52 Week Low
- NMT $9.05
- NTRB $2.98
- 52 Week High
- NMT $10.93
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- NMT 42.24
- NTRB 34.14
- Support Level
- NMT $11.48
- NTRB $7.00
- Resistance Level
- NMT $11.60
- NTRB $6.99
- Average True Range (ATR)
- NMT 0.08
- NTRB 0.47
- MACD
- NMT -0.01
- NTRB -0.15
- Stochastic Oscillator
- NMT 6.67
- NTRB 0.00
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.